UB Paderborn / Katalog / Suche / in CDI

Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial

The Lancet (British edition), 2014-03, Vol.383 (9919), p.807-814

2014

Link zum Volltext

Verfügbarkeit prüfen

Human Immune Responses to Burkholderia pseudomallei Characterized by Protein Microarray Analysis

The Journal of infectious diseases, 2011-04, Vol.203 (7), p.1002-1011

2011

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Recurrent Melioidosis in Northeast Thailand

Clinical infectious diseases, 2006-10, Vol.43 (8), p.979-986

2006

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Controlled Trial of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Sepsis Due to Melioidosis in Thailand

Clinical infectious diseases, 2007-08, Vol.45 (3), p.308-314

2007

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Melioidosis and Bacteremic Melioidosis

Clinical infectious diseases, 1999-08, Vol.29 (2), p.408-413

1999

Link zum Volltext

Verfügbarkeit prüfen

Melioidosis in 6 Tsunami Survivors in Southern Thailand

Clinical infectious diseases, 2005-10, Vol.41 (7), p.982-990

2005

Link zum Volltext

Verfügbarkeit prüfen

Two Randomized Controlled Trials of Ceftazidime Alone versus Ceftazidime in Combination with Trimethoprim-Sulfamethoxazole for the Treatment of Severe Melioidosis

Clinical infectious diseases, 2005-10, Vol.41 (8), p.1105-1113

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Imipenem and Ceftazidime as Therapy for Severe Melioidosis

Clinical infectious diseases, 1999-08, Vol.29 (2), p.381-387

1999

Link zum Volltext

Verfügbarkeit prüfen

Addition of Trimethoprim-Sulfamethoxazole to Ceftazidime during Parenteral Treatment of Melioidosis Is Not Associated with a Long-Term Outcome Benefit

Clinical infectious diseases, 2007-08, Vol.45 (4), p.521-523

2007

Link zum Volltext

Verfügbarkeit prüfen

Soluble Granzymes Are Released during Human Endotoxemia and in Patients with Severe Infection Due to Gram-Negative Bacteria

The Journal of infectious diseases, 2000-07, Vol.182 (1), p.206-213

2000

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Chloramphenicol, Trimethoprim-Sulfamethoxazole, and Doxycycline with Doxycycline Alone as Maintenance Therapy for Melioidosis

Clinical infectious diseases, 1999-08, Vol.29 (2), p.375-380

1999

Link zum Volltext

Verfügbarkeit prüfen

The CXC Chemokines Gamma Interferon (IFN-γ)-Inducible Protein 10 and Monokine Induced by IFN-γ Are Released during Severe Melioidosis

Infection and Immunity, 2000-07, Vol.68 (7), p.3888-3893

2000

Link zum Volltext

Verfügbarkeit prüfen

Antilipopolysaccharide II: An Antibody Protective Against Fatal Melioidosis

Clinical infectious diseases, 1999-10, Vol.29 (4), p.813-818

1999

Link zum Volltext

Verfügbarkeit prüfen

Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand

The Journal of infectious diseases, 1989-05, Vol.159 (5), p.890

1989

Link zum Volltext

Verfügbarkeit prüfen

Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis

Clinical infectious diseases, 2011-03, Vol.52 (6), p.717-725

2011

Link zum Volltext

Verfügbarkeit prüfen

Human Immune Responses to Burkholderia pseudomallei Characterized by Protein Microarray Analysis

The Journal of infectious diseases, 2011-04, Vol.203 (7), p.1002-1011

2011

Link zum Volltext

Verfügbarkeit prüfen

Empirical Cephalosporin Treatment of Melioidosis

Clinical infectious diseases, 1999-06, Vol.28 (6), p.1328-1328

1999

Link zum Volltext

Verfügbarkeit prüfen

Elevated Serum Procalcitonin Levels in Patients with Melioidosis

Clinical infectious diseases, 1995-03, Vol.20 (3), p.641-645

1995

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Quantitative Bacteremia in Septicemic Melioidosis

Clinical infectious diseases, 1995-12, Vol.21 (6), p.1498-1500

1995

Link zum Volltext

Verfügbarkeit prüfen

Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis (53.3)

The Journal of immunology (1950), 2011-04, Vol.186 (1_Supplement), p.53-53.3

2011

Link zum Volltext

Verfügbarkeit prüfen

Elevated Plasma Concentrations of Interferon (IFN)-γ and the IFN-γ—Inducing Cytokines Interleukin (IL)-18, IL-12, and IL-15 in Severe Melioidosis

The Journal of infectious diseases, 1999-12, Vol.180 (6), p.1878-1885

1999

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Cytokine Concentrations (Tumor Necrosis Factor-α, Interleukin-6, and Interleukin-10) and Clinical Parameters in Severe Melioidosis

The Journal of infectious diseases, 2000-02, Vol.181 (2), p.621-625

2000

Link zum Volltext

Verfügbarkeit prüfen

Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies

Infection and Immunity, 1997-09, Vol.65 (9), p.3648-3653

1997

Link zum Volltext

Verfügbarkeit prüfen

Diabetes Mellitus, Insulin, and Melioidosis in Thailand

Clinical infectious diseases, 2003-03, Vol.36 (5), p.e71-e72

2003

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial

Human Immune Responses to Burkholderia pseudomallei Characterized by Protein Microarray Analysis

Risk Factors for Recurrent Melioidosis in Northeast Thailand

A Randomized Controlled Trial of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Sepsis Due to Melioidosis in Thailand

Risk Factors for Melioidosis and Bacteremic Melioidosis

Melioidosis in 6 Tsunami Survivors in Southern Thailand

Two Randomized Controlled Trials of Ceftazidime Alone versus Ceftazidime in Combination with Trimethoprim-Sulfamethoxazole for the Treatment of Severe Melioidosis

Comparison of Imipenem and Ceftazidime as Therapy for Severe Melioidosis

Addition of Trimethoprim-Sulfamethoxazole to Ceftazidime during Parenteral Treatment of Melioidosis Is Not Associated with a Long-Term Outcome Benefit

A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial

Soluble Granzymes Are Released during Human Endotoxemia and in Patients with Severe Infection Due to Gram-Negative Bacteria

A Comparison of Chloramphenicol, Trimethoprim-Sulfamethoxazole, and Doxycycline with Doxycycline Alone as Maintenance Therapy for Melioidosis

The CXC Chemokines Gamma Interferon (IFN-γ)-Inducible Protein 10 and Monokine Induced by IFN-γ Are Released during Severe Melioidosis

Antilipopolysaccharide II: An Antibody Protective Against Fatal Melioidosis

Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand

Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis

Human Immune Responses to Burkholderia pseudomallei Characterized by Protein Microarray Analysis

Empirical Cephalosporin Treatment of Melioidosis

Elevated Serum Procalcitonin Levels in Patients with Melioidosis

Prognostic Significance of Quantitative Bacteremia in Septicemic Melioidosis

Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis (53.3)

Elevated Plasma Concentrations of Interferon (IFN)-γ and the IFN-γ—Inducing Cytokines Interleukin (IL)-18, IL-12, and IL-15 in Severe Melioidosis

Prognostic Value of Cytokine Concentrations (Tumor Necrosis Factor-α, Interleukin-6, and Interleukin-10) and Clinical Parameters in Severe Melioidosis

Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies

Diabetes Mellitus, Insulin, and Melioidosis in Thailand

Aktive Filter

Suchergebnisse filtern